Health Condition 1: R000- Tachycardia, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with IST (resting daytime sinus rate of more than 100 beats per minute and/or average 24-h Holter ECG HR of more than 90 beats per minute) by the treating physician and started on ivabradine or beta blockers during the study period
Exclusion criteria
Exclusion criteria: Secondary causes of sinus tachycardia (including anaemia, hyperthyroidism, infections, hypovolemia, or drugs), previous atrial or ventricular arrhythmias (i.e. atrial fibrillation/flutter, supraventricular arrhythmias, nonsustained or sustained ventricular arrhythmias), structural heart diseases, postural orthostatic tachycardia syndrome, sinus nodal re-entrant tachycardia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Determine & Compare the reduction in resting HR & peak HR of Inappropriate Sinus TachycardiaTimepoint: At follow up after one month | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To study demographic profile of IST patients 2) Collection of Adverse Drug Reactions (ADRs reported) 3) Pharmacoeconomic evaluation of the treatments using a suitable model 4) To assess the quality of life using European Heart Association EHRA score & SF-36 questionnaire Timepoint: At end of study | — |
Countries
India
Contacts
Kasturba Medical College,Manipal Academy of Higher Education